Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
about
Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2Rare mutations in renal sodium and potassium transporter genes exhibit impaired transport function.Developmental changes in renal tubular transport-an overview.Genetic causes of hypomagnesemia, a clinical overviewPharmGKB summary: Diuretics pathway, pharmacodynamics.Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome.Flufenamic acid as an ion channel modulator.Rare inherited kidney diseases: challenges, opportunities, and perspectives.Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administrationIndomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndromeA severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin.Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosisGitelman syndrome in a South African family presenting with hypokalaemia and unusual food cravings.Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population.Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like SyndromeGitelman or Bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation.Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene.Antenatal bartter syndrome: a review.The molecular basis of blood pressure variation.Classic Bartter syndrome complicated with profound growth hormone deficiency: a case report.ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.Vasopressin regulation of sodium transport in the distal nephron and collecting duct.Pathophysiology and clinical presentations of salt-losing tubulopathies.Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome.Urinary proteomics for the study of genetic kidney diseases.Potassium regulation in the neonate.Dynamic coupling between TRPV4 and Ca2+-activated SK1/3 and IK1 K+ channels plays a critical role in regulating the K+-secretory BK channel in kidney collecting duct cells.Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach.Paradoxical hypertension and salt wasting in Type II Bartter syndromeSPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.Gitelman syndrome in an infant.Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.Unusual Complication of Multidrug Resistant Tuberculosis.Acetyl salicylic acid treatment in neonatal Bartter syndrome--a commentary letter.Novel missense mutations of WNK1 in patients with hypokalemic salt-losing tubulopathies.Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes.
P2860
Q28593760-5A1BDF0C-1710-42BA-B320-BE99E29CB3CDQ33557328-660E9086-E209-44F9-B055-9492C093B86DQ33639194-55FC99A6-F9F5-4BB3-A7D7-69AF8995A91AQ33715342-C0749B21-40BB-44BB-8172-C721E5DA4A7FQ33855431-766B2E35-CA20-4BB1-B504-CC95269454B8Q33897714-5E1A513C-25E5-4706-A0F6-E8072D9DA0D4Q33978847-D85EA979-3AC9-4BEF-B8CB-B016D1F824DEQ34054113-52D1EDF5-3075-473D-B1E0-EA5A2ED09795Q34206428-D90900AE-6380-4352-B88A-75DA9BE7557EQ34800154-78A9A7CA-E8A7-4AE3-86FD-D6C8B98AD9E6Q34880742-72AA5371-F5F4-42D3-A880-7833AF1C6205Q35027295-5AFEDEF8-B4D7-4C94-8CAA-4CC0C2DB818DQ35227562-9B7DECB5-CA18-4068-B931-5BE01F6A55FAQ35891699-8062BFFF-6780-48BD-8853-1531CA3D2BA3Q35900778-834D12BA-E32E-4CC9-B511-AB84011CEEFBQ36212844-FFB800B6-6F71-4101-992A-2529AD4A69DFQ36261670-A78844CF-D68D-427A-A02E-A64131A2CA97Q36432893-8A8CB4B0-F1B6-4CEE-BC6E-0DCE6CC85E71Q36461569-5657D02E-DD8E-448D-A427-87F710ADF2E7Q36705399-057D4969-20C8-4EFA-97CF-ADDDCABD68F9Q37687103-FB788E5A-B7F1-4865-B57F-2F876E47C856Q38003986-D7737DBA-5BA8-4DB8-8B53-C04C90830CB5Q38024058-75DC2375-769D-47C3-9971-02A1763DBD4BQ38174651-9221B211-510A-4329-B2AF-4334EEFCC8D6Q38391564-B41F23DF-9C5E-4D51-B5CE-8F816EDCD89CQ38515104-272E5D8F-3B28-4B7B-9ABA-51DCA7D70B44Q38547860-DE70B7A4-599B-42D5-B644-232F7C00A8FFQ38669157-3E1C2017-10DB-4647-9755-E91722D0436AQ38677349-AFACCCF8-10F7-4A9B-9A4C-E7D922C4E9D5Q38854251-EF3B7057-94E7-47B8-A743-4592F73E93A9Q38919787-CDEDF38D-8BA5-4275-9336-6B9108A49A96Q39680505-6906BF21-2C84-48E0-A017-CEECA5E81973Q39720126-66DE36F6-6C23-4AA8-B58F-A1E14D882A12Q39859076-29ED9946-0CDB-4476-83BE-800C162B5C79Q41605076-0C6F2032-5AFA-4BC1-81E3-BD1B43938AC4Q41673622-8A08A3A5-68A0-465F-9BA7-9B313EEC90B9Q42717939-70C84B04-E2AA-48EF-B869-D7A214CCF7ECQ42767147-DB31DD04-1F7C-4133-8833-A1A651C49C9CQ43767582-6D4A917B-5529-46CD-84C5-BD4744A76957Q43800096-FB42E8AA-58B6-4376-A39B-46A4FAA8045F
P2860
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@ast
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@en
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@nl
type
label
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@ast
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@en
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@nl
prefLabel
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@ast
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@en
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@nl
P2860
P921
P1433
P1476
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
@en
P2093
Schlingmann KP
Seyberth HW
P2860
P2888
P304
P356
10.1007/S00467-011-1871-4
P577
2011-10-01T00:00:00Z
P5875
P6179
1012744444